Uschi Keszler Presents the Pennies in Action Fund


Our Current project is to raise funds to benefit the breast cancer vaccine research of Dr. Brian Czerniecki of the Hospital of the University of Pennsylvania. His research is cutting edge, and we believe strongly in his vision. Our starting goal is to raise $1,000,000 to help fund the second phase clinical trial of the vaccine.

Dr. Czerniecki is a highly recognized and respected oncological surgeon and researcher, who specializes in the least invasive means to treat breast cancer. He has had positive results in the first phase trial of his vaccine, which was funded by the National Institutes of Health (NIH). Our goal is to make certain he has the funds he needs for the next steps in his research.

Check out the links at the bottom of the page to learn more.

contact information for the Phase 2 trial -
A Randomized Trial of HER-2/neu Pulsed DC1 Vaccine for Patients with DCIS
For information please contact:
Jeanne Schueller, Research Project Manager, Department of Surgery
(office) 215-349-8399
(fax) 215-662-3179
jeanne.schueller@uphs.upenn.edu

interview with Dr. Czernieki - click here to watch

A Randomized Trial of HER-2/neu Pulsed DC1 Vaccine for Patients with DCIS
information on the 2nd phase of the Clinical Trial of Dr. Czerniecki's breast cancer vaccine research -  includes a description of the trial, and contact information for taking part in the trial

Professional Biography of Dr. Brian Czerniecki                                
information on Dr. Czerniecki and a description of his breast cancer vaccine research

OncoLink  Interview with Dr. Czerniecki                                                                                                      
interview from the first trial of the vaccine

Oncology Times  Dendritic Cell Vaccine Induces Strong Immune Response Against DCIS                     
mention of the first trial and results - it is the fourth segment of the article
(scroll down the page to read)

Cancer Review   Development of Vaccines for High-Risk Ductal Carcinoma In situ of the Breast             
Cancer Review   Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with   Staged Interleukin-12 Burst Secretion
                                                                                                  
these are scientific articles - but they are readable - and they give a lot of information on the research to read the full articles, click the link for Full Text on the right-hand side of the page

Testimonial for Dr. Czerniecki's Research
from Dr. Bruce Levine, Director of the Clinical Cell and Vaccine Production Facility, Abramson Cancer Center at the University of Pennsylvania


Proposal for Dr. Czerniecki's Stand Up To Cancer Dream Team
Dr. Czerniecki is heading one the Dream Teams applying for funding raised by Stand Up To Cancer. This is the proposal submitted to the selection committee


Check our Links page for more links to Dr. Czerniecki - his background and his research. Also, for a letter announcing the partnership of Uschi Keszler’s Pennies in Action® with PENN Medicine to raise funds for Dr. Czerniecki’s research.